Clinical Trial Detail

NCT ID NCT04294225
Title Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

breast carcinoma

Therapies

Anastrozole + Letrozole

Age Groups: adult senior

Additional content available in CKB BOOST